4//SEC Filing
Ahmed Mahiuddin 4
Accession 0001104659-20-064258
CIK 0001722964other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:15 PM ET
Size
6.8 KB
Accession
0001104659-20-064258
Insider Transaction Report
Form 4
Ahmed Mahiuddin
Sr. VP & Chief Scientific Off
Transactions
- Sale
Common Stock
2020-05-19$39.24/sh−10,000$392,403→ 200,000 total - Sale
Common Stock
2020-05-18$39.49/sh−19,492$769,675→ 210,000 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $ 39.000 to $ 40.3000. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $ 38.6300 to $ 39.5750. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Y-mAbs Therapeutics, Inc.
CIK 0001722964
Entity typeother
Related Parties
1- filerCIK 0001799304
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 4:15 PM ET
- Size
- 6.8 KB